In vitro study demonstrates selective G-quadruplex DNA binding and near-infrared emission by a styryl-quinolinium probe in MCF-7 cells, suggesting targeted cancer imaging and therapeutic potential.
In this work, we report the discovery of a G-quadruplex DNA-selective and near-infrared (NIR-I) emissive G-quadruplex binder derived from a known styryl-quinolinium-based compound. This molecule is unique in its class, with an emission wavelength above 800 nm, and displays selective G-quadruplex binding. Among the synthesized molecules, compound 2 emerged as a selective and the best G-quadruplex binder through comparative studies and exhibited strong thermal stabilization on Pu22 G-quadruplex with a ΔTm of 21.7 °C (at a 1:3 DNA to ligand ratio). G-quadruplex DNA-binding studies showed that thermal stabilization was topology-dependent. CD, UV–vis, and docking studies were performed to confirm the binding of these compounds to the different G-quadruplexes. Solution NMR studies confirmed the binding of compound 2 to the Pu22 G-quadruplex DNA. Cell-based studies showed that compound 2 was significantly cytotoxic to MCF-7 cancer cells and was readily taken up by the cells. However, cell internalization studies showed contrasting changes in the internalization properties, with compound 2 displaying a significant population on the nuclear periphery, which was altogether different from its parent compound 1, which did not show such changes.
No takes yet. Share an insight, caveat, or question.
Metangle et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: